Trans-resveratrol (Jupiter Orphan Therapeutics)

N/A

Report date: 2025/11/10 16:44:57

Base Information

Drug NameTrans-resveratrol (Jupiter Orphan Therapeutics)
Drug Alias NameResveratrolJotrolresVidaJOT-105JOT-107 +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent deacetylase sirtuin 1 stimulants
TargetsNAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsAlzheimer DiseaseFriedreich AtaxiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJupiter Orphan Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesJupiter Neurosciences IncJupiter Orphan Therapeutics
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseFriedreich AtaxiaParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A